Symbol="GLYC"
AssetType="Common Stock"
Name="GlycoMimetics Inc"
Description="GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of new glucomimetic drugs to address unmet medical needs resulting from disease in the United States. The company is headquartered in Rockville, Maryland."
CIK="1253689"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="106648000"
EBITDA="-43492552"
PERatio="None"
PEGRatio="0"
BookValue="0.968"
DividendPerShare="0"
DividendYield="0"
EPS="-0.73"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-582.46"
ReturnOnAssetsTTM="-0.363"
ReturnOnEquityTTM="-0.651"
RevenueTTM="75000"
GrossProfitTTM="75000"
DilutedEPSTTM="-0.73"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="5.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1154.6"
PriceToBookRatio="2.408"
EVToRevenue="706.21"
EVToEBITDA="-1.212"
Beta="2.057"
num_52WeekHigh="4.16"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.816"
num_200DayMovingAverage="1.796"
SharesOutstanding="64246000"
DividendDate="None"
ExDividendDate="None"
symbol="GLYC"
open="1.66"
high="1.73"
low="1.63"
price="1.66"
volume="110367.00"
latest_trading_day="2023-07-21"
previous_close="1.64"
change="0.03"
change_percent="1.5291%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="320261"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="514"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_negative_thumbnail_id_2="153"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
